RxNorm 2602751 NDC Crossover
treprostinil 16 MCG Inhalation Powder
Related NDC Codes to RxNorm Concept 2602751
The following NDC codes crossover to the RxNorm Concept 2602751. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
66302-600 | Tyvaso Dpi | United Therapeutics Corporation | |||||
66302-610 | Tyvaso Dpi | Treprostinil | Kit | United Therapeutics Corporation | ACTIVE | ||
66302-616 | Tyvaso Dpi | Treprostinil | Inhalant | Oral | United Therapeutics Corporation | ACTIVE | |
66302-620 | Tyvaso Dpi | Treprostinil | Kit | United Therapeutics Corporation | ACTIVE | ||
66302-630 | Tyvaso Dpi | Treprostinil | Kit | United Therapeutics Corporation | ACTIVE | ||
66302-632 | Tyvaso Dpi | Treprostinil | Inhalant | Oral | United Therapeutics Corporation | ACTIVE | |
66302-640 | Tyvaso Dpi | Treprostinil | Kit | United Therapeutics Corporation | ACTIVE | ||
66302-648 | Tyvaso Dpi | Treprostinil | Inhalant | Oral | United Therapeutics Corporation | ACTIVE | |
66302-650 | Tyvaso Dpi | Treprostinil | Kit | United Therapeutics Corporation | ACTIVE | ||
66302-664 | Tyvaso Dpi | Treprostinil | Inhalant | Oral | United Therapeutics Corporation | ACTIVE | |
66302-680 | Tyvaso Dpi | Treprostinil | Inhalant | Oral | United Therapeutics Corporation | ACTIVE | |
66302-716 | Tyvaso Dpi | Treprostinil | Inhalant | Oral | United Therapeutics Corporation | ACTIVE | |
66302-720 | Tyvaso Dpi | Treprostinil | Kit | United Therapeutics Corporation | ACTIVE | ||
66302-732 | Tyvaso Dpi | Treprostinil | Inhalant | Oral | United Therapeutics Corporation | ACTIVE | |
66302-748 | Tyvaso Dpi | Treprostinil | Inhalant | Oral | United Therapeutics Corporation | ACTIVE | |
66302-764 | Tyvaso Dpi | Treprostinil | Inhalant | Oral | United Therapeutics Corporation | ACTIVE | |
66302-780 | Tyvaso Dpi | Treprostinil | Inhalant | Oral | United Therapeutics Corporation | ACTIVE |